Vice President, Head of Medical – Oncology

Job Title: Vice President, Head of Medical – Oncology
Department: CMO Office
Reports To: Chief Medical Officer
Location: Raleigh (United States) or Dublin (Ireland)
Level: Executive / VP

Position Summary

Azurity Pharmaceuticals is seeking a Vice President, Head of Medical – Oncology to provide senior medical and scientific leadership across Azurity’s oncology portfolio in global markets. This role is accountable for defining and executing integrated medical strategies that support scientific differentiation, clinical value, and lifecycle advancement of oncology products across development, launch, and commercialization.

Reporting directly to the Chief Medical Officer, this executive will oversee a team of Medical Leads aligned to oncology brands and indications. The role will partner closely with Commercial Brand Executives and Franchise Portfolio Management to ensure medical strategy iand inpouts embedded into brand planning, portfolio prioritization, and long-range value creation - while upholding the highest standards of scientific integrity, compliance, and patient centricity.

Key Responsibilities

Oncology Medical Strategy Leadership
• Own and drive end-to-end medical strategy for the oncology portfolio across global markets, ensuring alignment with Azurity’s enterprise medical vision and oncology-specific objectives.
• Define portfolio-level oncology medical strategic imperatives, including unmet need, scientific differentiation, biomarker strategy, evidence requirements, and lifecycle opportunities.
• Ensure consistent medical positioning and strategic clarity across oncology brands, indications, and lines of therapy globally.

Leadership of Medical Leads
• Lead, mentor, and develop a team of Medical Leads supporting oncology brands and programs.
• Establish clear frameworks, standards, and expectations for oncology brand-level medical strategy development, execution, and measurement.
• Ensure Medical Strategy function as highly collaborative, credible scientific experts and trusted strategic partners by Commercial Brand Executives and Franchise Portfolio leaders.

Integrated Brand & Lifecycle Planning
• Partner closely with Commercial Brand Executives to align oncology portfolio’s medical strategy with overall brand strategy, launch planning and execution - while maintaining appropriate medical function’s compliance.
• Collaborate with Franchise Portfolio Management to inform portfolio prioritization, indication sequencing and timing, formulation strategies, and long-range oncology lifecycle planning across global markets.
• Oversee medical contributions to integrated brand plans, launch readiness, post-launch optimization, and expansion strategies.

Evidence Generation & Scientific Insight
• Guide oncology evidence generation strategies, including alignment with Clinical Development, investigator-initiated studies (IIS), real-world evidence (RWE), registries, and post-marketing research.
• Ensure oncology medical strategies are grounded in robust clinical data, translational science, and evolving global standards of care.
• Leverage insights (including evolving treatment landscape and new market entrants) from MSLs, KOLs, advisory boards, and scientific congresses to continuously refine oncology medical strategy.

Cross-Functional & Executive Partnership
• Serve as the senior medical strategy partner for oncology across Commercial, Market Access, Regulatory, Clinical Development, Safety, and Global Medical Operations.
• Provide medical leadership input into value, access, HTA, and reimbursement discussions for oncology products in global markets.
• Support business development, due diligence, and portfolio evaluation activities related to oncology assets.

Governance & Scientific Integrity
• Ensure all oncology medical strategies and activities comply with global medical governance standards, regulatory requirements, and ethical principles.
• Partner with Legal and Compliance to maintain appropriate collaboration and separation between medical and commercial activities, particularly in highly regulated oncology environments.

Executive Influence & Representation
• Act as a trusted advisor to the Chief Medical Officer on oncology portfolio strategy, scientific risk, and opportunity assessment.
• Represent Oncology Medical Strategy in senior leadership forums, governance committees, and cross-functional decision-making bodies.
• Ensure a clear, unified medical voice for oncology across global markets.

Qualifications

Education
• Advanced degree required: MD, PharmD, PhD, or equivalent medical/scientific degree.

Experience
• 15+ years of experience in Medical Affairs roles within pharmaceutical or biotech organizations.
• Expert understanding of life cycle management process

• Demonstrated Medical launch success within pharmaceutical and/or biotech organizations

 -Significant experience in oncology, including leadership of oncology medical strategy, clinical programs, or medical affairs teams.
• Demonstrated leadership of portfolio- or franchise-based medical strategy, including oversight of senior medical leaders (e.g., Medical Leads).
• Proven success partnering closely with Commercial Brand leadership and Portfolio Management in a compliant, matrixed environment.
• Experience supporting multiple oncology launches, indications, or lifecycle expansions in global markets.

Skills & Competencies
• Deep oncology expertise with strong scientific and clinical acumen.
• Strategic portfolio-level thinking with the ability to translate oncology science into long-term medical and business value.
• Proven people leader with experience developing Medical Affairs professionals
• Excellent executive communication, influence, and stakeholder-management skills.
• High ethical standards, patient-centric orientation, and commitment to scientific excellence.

Preferred Qualifications
• Experience across solid tumors and/or hematologic malignancies.
• Experience working across US and international oncology markets.
• Prior experience in organizations with franchise or portfolio operating models.
• Experience supporting precision medicine, biomarkers, or companion diagnostics.

Travel
• Willingness to travel domestically and internationally up to 25–35%, as required.

#LI-Hybrid